217 related articles for article (PubMed ID: 23917320)
1. Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
Tarning J; Kloprogge F; Dhorda M; Jullien V; Nosten F; White NJ; Guerin PJ; Piola P
Antimicrob Agents Chemother; 2013 Oct; 57(10):5096-103. PubMed ID: 23917320
[TBL] [Abstract][Full Text] [Related]
2. Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.
Nyunt MM; Nguyen VK; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Mwima MW; Achan J; Aweeka F; Parikh S; Mwebaza N
Antimicrob Agents Chemother; 2015 Dec; 60(3):1274-82. PubMed ID: 26666942
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
Tarning J; McGready R; Lindegardh N; Ashley EA; Pimanpanarak M; Kamanikom B; Annerberg A; Day NP; Stepniewska K; Singhasivanon P; White NJ; Nosten F
Antimicrob Agents Chemother; 2009 Sep; 53(9):3837-46. PubMed ID: 19564366
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
McGready R; Stepniewska K; Lindegardh N; Ashley EA; La Y; Singhasivanon P; White NJ; Nosten F
Eur J Clin Pharmacol; 2006 Dec; 62(12):1021-31. PubMed ID: 17053895
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
Tarning J; Kloprogge F; Piola P; Dhorda M; Muwanga S; Turyakira E; Nuengchamnong N; Nosten F; Day NP; White NJ; Guerin PJ; Lindegardh N
Malar J; 2012 Aug; 11():293. PubMed ID: 22913677
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F
PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria.
Djimdé AA; Tekete M; Abdulla S; Lyimo J; Bassat Q; Mandomando I; Lefèvre G; Borrmann S;
Antimicrob Agents Chemother; 2011 Sep; 55(9):3994-9. PubMed ID: 21670177
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.
Hietala SF; Mårtensson A; Ngasala B; Dahlström S; Lindegårdh N; Annerberg A; Premji Z; Färnert A; Gil P; Björkman A; Ashton M
Antimicrob Agents Chemother; 2010 Nov; 54(11):4780-8. PubMed ID: 20713675
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.
Mosha D; Guidi M; Mwingira F; Abdulla S; Mercier T; Decosterd LA; Csajka C; Genton B
Antimicrob Agents Chemother; 2014 Aug; 58(8):4583-92. PubMed ID: 24867986
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.
Tchaparian E; Sambol NC; Arinaitwe E; McCormack SA; Bigira V; Wanzira H; Muhindo M; Creek DJ; Sukumar N; Blessborn D; Tappero JW; Kakuru A; Bergqvist Y; Aweeka FT; Parikh S
J Infect Dis; 2016 Oct; 214(8):1243-51. PubMed ID: 27471317
[TBL] [Abstract][Full Text] [Related]
11. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.
Achan J; Tibenderana JK; Kyabayinze D; Wabwire Mangen F; Kamya MR; Dorsey G; D'Alessandro U; Rosenthal PJ; Talisuna AO
BMJ; 2009 Jul; 339():b2763. PubMed ID: 19622553
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria.
Lohy Das J; Rulisa S; de Vries PJ; Mens PF; Kaligirwa N; Agaba S; Tarning J; Karlsson MO; Dorlo TPC
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061282
[TBL] [Abstract][Full Text] [Related]
14. Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).
Tiono AB; Tinto H; Alao MJ; Meremikwu M; Tshefu A; Ogutu B; Ouedraogo A; Lingani M; Cousin M; Lefèvre G; Jain JP; Duparc S; Hamed K
Malar J; 2015 Apr; 14():157. PubMed ID: 25886021
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa.
Onyamboko MA; Hoglund RM; Lee SJ; Kabedi C; Kayembe D; Badjanga BB; Turner GDH; Jackson NV; Tarning J; McGready R; Nosten F; White NJ; Day NPJ; Fanello C
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818818
[TBL] [Abstract][Full Text] [Related]
16. Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects.
Lefèvre G; Carpenter P; Souppart C; Schmidli H; Martin JM; Lane A; Ward C; Amakye D
J Clin Pharmacol; 2002 Oct; 42(10):1147-58. PubMed ID: 12362930
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.
Piola P; Nabasumba C; Turyakira E; Dhorda M; Lindegardh N; Nyehangane D; Snounou G; Ashley EA; McGready R; Nosten F; Guerin PJ
Lancet Infect Dis; 2010 Nov; 10(11):762-9. PubMed ID: 20932805
[TBL] [Abstract][Full Text] [Related]
18. Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.
Kloprogge F; Workman L; Borrmann S; Tékété M; Lefèvre G; Hamed K; Piola P; Ursing J; Kofoed PE; Mårtensson A; Ngasala B; Björkman A; Ashton M; Friberg Hietala S; Aweeka F; Parikh S; Mwai L; Davis TME; Karunajeewa H; Salman S; Checchi F; Fogg C; Newton PN; Mayxay M; Deloron P; Faucher JF; Nosten F; Ashley EA; McGready R; van Vugt M; Proux S; Price RN; Karbwang J; Ezzet F; Bakshi R; Stepniewska K; White NJ; Guerin PJ; Barnes KI; Tarning J
PLoS Med; 2018 Jun; 15(6):e1002579. PubMed ID: 29894518
[TBL] [Abstract][Full Text] [Related]
19. Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
Huang L; Carey V; Lindsey JC; Marzan F; Gingrich D; Graham B; Barlow-Mosha L; Ssemambo PK; Kamthunzi P; Nachman S; Parikh S; Aweeka FT;
PLoS One; 2017; 12(10):e0186589. PubMed ID: 29065172
[TBL] [Abstract][Full Text] [Related]
20. Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.
Byakika-Kibwika P; Lamorde M; Mayito J; Nabukeera L; Namakula R; Mayanja-Kizza H; Katabira E; Ntale M; Pakker N; Ryan M; Hanpithakpong W; Tarning J; Lindegardh N; de Vries PJ; Khoo S; Back D; Merry C
J Antimicrob Chemother; 2012 Sep; 67(9):2213-21. PubMed ID: 22687893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
